Oral Anticoagulation Monotherapy After Endovascular Therapy for Peripheral Artery Disease in Patients Requiring Anticoagulation

Oral Anticoagulation Monotherapy After Endovascular Therapy for Peripheral Artery Disease in Patients Requiring Anticoagulation - Oral Anticoagulation Monotherapy After Endovascular Therapy for Peripheral Artery Disease in Patients Requiring Anticoagulation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000040985

Enrollment

Registered

2020-09-01

Start date

2020-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral artery disease

Interventions

Oral anticoagulate monotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with peripheral artery disease undergoing endovascular therapy Patients requiring anticoagulate therapy

Exclusion criteria

Exclusion criteria: intolerance for anticoagulate therapy

Design outcomes

Primary

Measure	Time frame
Patency at 1-year	—

Secondary

Measure	Time frame
Thrombosis Restenosis Target lesion revascularization Bleeding events	—

Countries

Japan

Contacts

Public ContactKojiro Miki

Hyogo College of Medicine Cardiovascular and renal disease medicine

hpxkg043@ybb.ne.jp0798-45-6553

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026